Citi Knock-Out JNJ/ DE000KH3SXJ7 /
| 23/05/2024 19:38:13 | Diferencia-0.360 | Bid21:59:51 | Ask- | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
|---|---|---|---|---|---|---|---|
| 1.450EUR | -19.89% | 1.420 Volumen de oferta: 3,700 |
- Tamaño/ Volumen/ Formato de Ask: - |
JOHNSON + JOHNSON ... | 134.9493 - | 31/12/2078 | Call |
GlobeNewswire
23:06
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...
GlobeNewswire
23:05
Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
GlobeNewswire
23:05
BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...
GlobeNewswire
23:05
I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...
GlobeNewswire
23:05
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...
GlobeNewswire
23:05
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
23:05
NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...
GlobeNewswire
23:05
Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...
GlobeNewswire
23:04
Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...
GlobeNewswire
23:03
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...
GlobeNewswire
23:01
Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...
GlobeNewswire
23:01
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire
23:01
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...
GlobeNewswire
23:00
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...
GlobeNewswire
23:00
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...
GlobeNewswire
23:00
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire
23:00
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire
23:00
MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBIN...
GlobeNewswire
23:00
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...
GlobeNewswire
23:00
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página
